MedTrace Logo

Refining Local-Regional Therapy for IBC

NCT04636710 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-12-29

No results posted yet for this study

Summary

This Feasibility study is trying to determine:

* If Lymphoscintigraphy (imaging of the lymphatic drainage patterns) is effective in demonstrating the drainage to the sentinel lymph nodes in patients with inflammatory breast cancer.
* The likelihood of identifying the sentinel lymph nodes in the operating room, using both blue dye and the radioactive substance used for lymphoscintigraphy.
* The incidence of lymphedema (arm swelling which occurs after lymph node surgery) in women with inflammatory breast cancer
* Outcomes for women with inflammatory breast cancer, whether or not the sentinel lymph nodes can be identified.

Conditions

Interventions

PROCEDURE

Lymphoscintigraphy

An imaging procedure using an injected radioactive substance or dye to identify lymph drainage A doctor reviews the images to identify the sentinel lymph nodes based on where the dye goes to first.

Sponsors & Collaborators

Principal Investigators

  • Faina Nahklis, MD · Dana-Farber Cancer Institute

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-02
Primary Completion
2027-12-01
Completion
2028-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04636710 on ClinicalTrials.gov